Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma

Thumbnail
View
Author
Di Staso, Rossana ORCID
Casadei, Beatrice ORCID
Locke, Frederick ORCID
Voorhees, Timothy ORCID
Kittai, Adam ORCID
Jain, Michael ORCID
Barba, Pere ORCID
IACOBONI, GLORIA ORCID
Date
2024-11-07
Permanent link
https://hdl.handle.net/11351/12439
DOI
10.1038/s41408-024-01183-8
ISSN
2044-5385
WOS
001352378700002
PMID
39511146
Share on TwitterShare on FacebookShare on TelegramShare on WhatsappShare on Linkedin

Show full item record
Keywords
CAR-T cells; Diffuse large B cell lymphoma
Bibliographic citation
Di Staso R, Casadei B, Locke FL, Jain M, Voorhees TJ, Kittai AS, et al. Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma. Blood Cancer J. 2024 Nov 7;14:197.
Audience
Professionals
This item appears in following collections

The following license files are associated with this item: